Menu
Search
|

Menu

Close
X

ImmuCell Corp ICCC.OQ (NASDAQ Stock Exchange Capital Market)

7.19 USD
+0.04 (+0.56%)
As of 3:59 PM EST
chart
Previous Close 7.15
Open 7.20
Volume 20
3m Avg Volume 2,689
Today’s High 7.20
Today’s Low 7.19
52 Week High 9.25
52 Week Low 5.00
Shares Outstanding (mil) 5.06
Market Capitalization (mil) 36.27
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

No Data Available
Sell Hold Buy

KEY STATS

Revenue (mm, USD)
FY17
10
FY16
10
FY15
10
EPS (USD)
FY17
-0.033
FY16
0.129
FY15
0.387
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
35.64
Price to Sales (TTM)
vs sector
3.48
8.67
Price to Book (MRQ)
vs sector
--
5.21
Price to Cash Flow (TTM)
vs sector
54.30
26.03
Total Debt to Equity (MRQ)
vs sector
--
15.38
LT Debt to Equity (MRQ)
vs sector
--
12.01
Return on Investment (TTM)
vs sector
--
13.57
Return on Equity (TTM)
vs sector
--
15.19

EXECUTIVE LEADERSHIP

David Tomsche
Independent Chairman of the Board, Since 2013
Salary: --
Bonus: --
Michael Brigham
President, Chief Executive Officer, Treasurer, Secretary, Director, Since 2000
Salary: $266,923.00
Bonus: --
Bobbi Brockmann
Vice President - Sales and Marketing, Director, Since 2018
Salary: $180,192.00
Bonus: --
Elizabeth Williams
Vice President - Manufacturing Operations, Since 2016
Salary: --
Bonus: --
Paul Wainman
Director, Since 2014
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

56 Evergreen Dr
PORTLAND   ME   04103-1066

Phone: +1207.8782770

ImmuCell Corporation is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries segment. The Company has developed products that provide immediate immunity to newborn dairy and beef cattle, and is developing product line extensions of its existing products that address mastitis. The Company's lead product, First Defense, is manufactured from cows' colostrum utilizing its vaccine and milk protein purification technologies. Its Wipe Out Dairy Wipes are made from a non-woven fabric that allows for a vigorous cleaning. It also developed California Mastitis Test (CMT), which is used for bulk tank, as well as individual cow sample monitoring and is used to determine which quarter of the udder is mastitic. Its product development initiative is Mast Out, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows.

SPONSORED STORIES